Literature DB >> 2315979

Using clinical data to determine vancomycin dosing parameters.

J K Birt1, M H Chandler.   

Abstract

The serum concentrations and pharmacokinetic parameters produced from standard doses of vancomycin were evaluated in 22 patients. The mean (+/- SD) half-life, clearance (Cl), and volume of distribution, respectively, were 6.2 (+/- 1.9) h, 79.2 (+/- 34.3) ml/min, and 0.54 (+/- 0.23) L/kg. Geometric regression analysis was used to determine significant correlations between Cl and creatinine clearance (CrCl) (p less than 0.001). The dosing method developed is based on the pharmacokinetic parameters of vancomycin derived from our patient data and the relationship between Cl and CrCl described by the following equation, Cl = (0.674) (CrCl) + 13.45 (r = 0.703). Predictive performance measures were used to compare our dosing method with that of the Matzke nomogram. Our method was found to be less biased and more precise in regards to predicted half-life and volume of distribution, while less biased with no difference in precision in regard to predicting clearance. We plan to use this dosing method at our institution to provide a more individualized initial dosing regimen for vancomycin. Other institutions may wish to use a similar approach to design a dosing nomogram specific for their patient population.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2315979     DOI: 10.1097/00007691-199003000-00017

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  12 in total

1.  Population pharmacokinetic analysis of vancomycin in patients with hematological malignancies.

Authors:  Dolores Santos Buelga; María del Mar Fernandez de Gatta; Emma V Herrera; Alfonso Dominguez-Gil; María José García
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

2.  Influence of renal function estimation on pharmacokinetic modeling of vancomycin in elderly patients.

Authors:  Anaïs Glatard; Laurent Bourguignon; Roger W Jelliffe; Pascal Maire; Michael N Neely; Sylvain Goutelle
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

Review 3.  An updated comparison of drug dosing methods. Part IV: Vancomycin.

Authors:  R D Pryka; K A Rodvold; S M Erdman
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

4.  Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children.

Authors:  Trevor N Johnson; Amin Rostami-Hodjegan; Geoffrey T Tucker
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

5.  Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients.

Authors:  Maria del Mar Fernández de Gatta Garcia; Natalia Revilla; Maria Victoria Calvo; Alfonso Domínguez-Gil; Amparo Sánchez Navarro
Journal:  Intensive Care Med       Date:  2006-12-13       Impact factor: 17.440

Review 6.  Pharmacokinetic optimisation of vancomycin therapy.

Authors:  W G Leader; M H Chandler; M Castiglia
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

7.  Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate.

Authors:  Adam Frymoyer; Adam L Hersh; Leslie Z Benet; B Joseph Guglielmo
Journal:  Pediatr Infect Dis J       Date:  2009-05       Impact factor: 2.129

8.  Population pharmacokinetic analysis of vancomycin using serum cystatin C as a marker of renal function.

Authors:  Akihiro Tanaka; Tetsuya Aiba; Takashi Otsuka; Katsuya Suemaru; Tatsuya Nishimiya; Tomoyoshi Inoue; Mitsuharu Murase; Yuji Kurosaki; Hiroaki Araki
Journal:  Antimicrob Agents Chemother       Date:  2009-11-23       Impact factor: 5.191

9.  Predictive performance of Vancomycin population pharmacokinetic models in Iranian patients underwent hematopoietic stem cell transplantation.

Authors:  Maryam Taghizadeh-Ghehi; Saeed Rezaee; Kheirollah Gholami; Molouk Hadjibabaie
Journal:  J Res Pharm Pract       Date:  2015 Jul-Sep

Review 10.  Intravenous Vancomycin Dosing in the Elderly: A Focus on Clinical Issues and Practical Application.

Authors:  Katie E Barber; Allison M Bell; Kayla R Stover; Jamie L Wagner
Journal:  Drugs Aging       Date:  2016-12       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.